JP2006520673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006520673A5 JP2006520673A5 JP2006509193A JP2006509193A JP2006520673A5 JP 2006520673 A5 JP2006520673 A5 JP 2006520673A5 JP 2006509193 A JP2006509193 A JP 2006509193A JP 2006509193 A JP2006509193 A JP 2006509193A JP 2006520673 A5 JP2006520673 A5 JP 2006520673A5
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- poly
- agent
- hojo
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 24
- 229920000642 polymer Polymers 0.000 claims 16
- 230000001225 therapeutic Effects 0.000 claims 15
- 229940079593 drugs Drugs 0.000 claims 13
- 230000002792 vascular Effects 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000004793 Polystyrene Substances 0.000 claims 3
- 229920001577 copolymer Polymers 0.000 claims 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims 3
- 239000004926 polymethyl methacrylate Substances 0.000 claims 3
- 229920002223 polystyrene Polymers 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 230000010261 cell growth Effects 0.000 claims 2
- 229920001519 homopolymer Polymers 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229920002285 poly(styrene-co-acrylonitrile) Polymers 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- ZPRUNJQKBXALCY-UHFFFAOYSA-N 4-[2-(4-methoxy-2,3,6-trimethylphenyl)propan-2-yl]phenol Chemical compound CC1=C(C)C(OC)=CC(C)=C1C(C)(C)C1=CC=C(O)C=C1 ZPRUNJQKBXALCY-UHFFFAOYSA-N 0.000 claims 1
- 210000003445 Biliary Tract Anatomy 0.000 claims 1
- 210000004556 Brain Anatomy 0.000 claims 1
- 210000001072 Colon Anatomy 0.000 claims 1
- 210000003238 Esophagus Anatomy 0.000 claims 1
- 210000002744 Extracellular Matrix Anatomy 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 claims 1
- 210000002307 Prostate Anatomy 0.000 claims 1
- 210000003437 Trachea Anatomy 0.000 claims 1
- 230000003444 anaesthetic Effects 0.000 claims 1
- 230000002429 anti-coagulation Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 1
- 230000001028 anti-proliferant Effects 0.000 claims 1
- 239000003529 anticholesteremic agent Substances 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 239000002282 antimigraine agent Substances 0.000 claims 1
- 239000003080 antimitotic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000004019 antithrombin Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000002452 interceptive Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002093 peripheral Effects 0.000 claims 1
- 229920002852 poly(2,6-dimethyl-1,4-phenylene oxide) polymer Polymers 0.000 claims 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 229920000098 polyolefin Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 200000000008 restenosis Diseases 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000002485 urinary Effects 0.000 claims 1
- 230000002227 vasoactive Effects 0.000 claims 1
- 230000000261 vasodilator Effects 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Claims (22)
- (a)埋め込み又は挿入可能医療器具基材、
(b)治療薬及び
(c)該埋め込み又は挿入可能医療器具基材の少なくとも一部の上に配置の放除領域
を含む治療薬放除医療器具であって、
該放除領域が(i)複数の相溶性ポリマーを含む第一相であって、該複数の相溶性ポリマーが互いに相溶性であってブレンドを形成する第一相と、(ii)該複数の相溶性ポリマーのいずれかもしくはすべて、または該相溶性ポリマーのブレンドに対して非相溶性である追加ポリマーを含む第二相を含み;ここで、
該放除領域が該医療器具を患者に埋め込むか又は挿入したとき該医療器具からの薬剤放除速度を制御する医療器具。 - 前記相溶性ポリマーのうちの少なくとも1つがホモポリマーである請求項1の治療薬放除医療器具。
- 前記相溶性ポリマーのうちの少なくとも1つが共重合体である請求項1の治療薬放除医療器具。
- 前記複数の相溶性ポリマーが一対の相溶性ポリマー対である請求項1の治療薬放除医療器具。
- 一対の相溶性ポリマーが(a)ポリ(ビニルブチラール)/ポリ(ビニルピロリドン)、(b)ポリ(2,6−ジメチル−1,4−フェニレンオキシド)/ポリスチレン、(c)テトラメチルビスフェノールA ポリカーボネート/ポリスチレン、(d)ポリ(エチレンオキサイド)/ポリ(メチルメタアクリレート)、(e)ポリ(フッ化ビニリデン)/ポリ(メチルメタアクリレート)、(f)ポリスチレン/ポリ(ビニルメチルエーテル)、(g)ポリ(メチルメタアクリレート)/ポリ(スチレン−コ−アクリロニトリル)、(h)ポリ(塩化ビニル)/ポリ(エチレン−コ−酢酸ビニル)及び(i)ポリ(スチレン−コ−無水マレイン酸/(ポリ(スチレン−コ−アクリロニトリル)から選択した請求項4の治療薬放除医療器具。
- 前記追加ポリマーがホモポリマーである請求項1の治療薬放除医療器具。
- 前記追加ポリマーが共重合体である請求項1の治療薬放除医療器具。
- 前記追加ポリマーが(i)一つ又はそれ以上のポリオレフィンポリマー鎖と(ii)一つ又はそれ以上の芳香族ビニルポリマー鎖を含む共重合体である請求項7の治療薬放除医療器具。
- 前記放除領域が治療薬含有領域上に配置のバリヤー領域である請求項1の治療薬放除医療器具。
- 前記放除領域が前記治療薬を含有する担体領域である請求項1の治療薬放除医療器具。
- 前記埋め込み又は挿入可能医療器具がカテーテル、ガイドワイヤー、バルーン、フィルター、ステント、ステントグラフト、血管グラフト、血管パッチ、シャント及び腔内舗装系から選択した請求項1の治療薬放除医療器具。
- 前記埋め込み又は挿入可能医療器具がステントである請求項1の治療薬放除医療器具。
- 前記埋め込み又は挿入可能医療器具が冠動脈管構造、末梢血管系、食道、気管、大腸、胆管、尿道、前立腺又は脳への埋め込み又は挿入に適応する請求項1の治療薬放除医療器具。
- 前記治療薬が抗トロンビン剤、抗増殖性薬、抗炎症薬、抗偏頭痛薬、細胞外基質生成及び組織化影響剤、抗悪性腫瘍薬、有糸分裂阻害剤、麻酔薬、抗凝血剤、血管細胞成長促進物質、血管細胞成長阻害剤、コレステロール降下剤、血管拡張薬及び内在性血管作動機構妨害薬からなる群から選択した請求項1の治療薬放除医療器具。
- 請求項1の治療薬放除医療器具を形成する方法であって、
(a)(i)一つ又はそれ以上の溶剤種、(ii)前記相溶性ポリマー及び(iii)前記追加ポリマーを含む溶液を提供し、
(b)該溶液を前記埋め込み又は挿入可能医療器材の表面に塗布し、且つ
(c)該溶液から溶剤を除去して放除領域を形成する事
を含む方法。 - 前記溶液が更に治療薬を含有する請求項15の方法。
- 前記溶液を治療薬剤含有領域上に塗布する請求項15の方法。
- 前記溶液を溶剤スプレー法で塗布する請求項15の方法。
- 患者へ治療薬を投与するためのシステムであって、
請求項1の治療薬放除医療器具を含み、ここで該治療薬放除医療器具が患者に埋め込まれるように構成されている、システム。 - 前記医療器具がカテーテル、ガイドワイヤー、バルーン、フィルター、ステント、ステントグラフト、血管グラフト、血管パッチ、シャント及び腔内舗装系から選択した請求項19のシステム。
- 前記医療器具が脈管構造に挿入される請求項20のシステム。
- 前記治療薬が再狭窄治療において放除される請求項21のシステム。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/382,552 US8313759B2 (en) | 2003-03-06 | 2003-03-06 | Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
PCT/US2004/006853 WO2004080397A2 (en) | 2003-03-06 | 2004-03-05 | Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2006520673A JP2006520673A (ja) | 2006-09-14 |
JP2006520673A5 true JP2006520673A5 (ja) | 2010-08-12 |
JP4662556B2 JP4662556B2 (ja) | 2011-03-30 |
Family
ID=32926917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006509193A Expired - Fee Related JP4662556B2 (ja) | 2003-03-06 | 2004-03-05 | 治療薬デリバリー制御に関する相溶性ポリマーブレンド含有埋め込み又は挿入可能医療器具 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8313759B2 (ja) |
EP (1) | EP1599229A2 (ja) |
JP (1) | JP4662556B2 (ja) |
WO (1) | WO2004080397A2 (ja) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020188037A1 (en) * | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
US7097850B2 (en) | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
US8211455B2 (en) * | 2002-06-19 | 2012-07-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
US9114199B2 (en) * | 2003-07-31 | 2015-08-25 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent |
WO2006078320A2 (en) | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
JP2006068378A (ja) * | 2004-09-03 | 2006-03-16 | Terumo Corp | 血管内留置物 |
US7919110B2 (en) | 2005-01-25 | 2011-04-05 | Boston Scientific Scimed, Inc. | Medical device drug release regions containing non-covalently bound polymers |
US7988987B2 (en) | 2005-01-25 | 2011-08-02 | Boston Scientific Scimed, Inc. | Medical devices containing crazed polymeric release regions for drug delivery |
US9125968B2 (en) * | 2005-03-30 | 2015-09-08 | Boston Scientific Scimed, Inc. | Polymeric/ceramic composite materials for use in medical devices |
US7517914B2 (en) | 2005-04-04 | 2009-04-14 | Boston Scientificscimed, Inc. | Controlled degradation materials for therapeutic agent delivery |
US8008395B2 (en) * | 2005-09-27 | 2011-08-30 | Boston Scientific Scimed, Inc. | Organic-inorganic hybrid particle material and polymer compositions containing same |
US8034874B2 (en) * | 2005-11-23 | 2011-10-11 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions that contain fluorocarbon-containing block copolymers |
US7713637B2 (en) * | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
MX2009007663A (es) | 2007-01-21 | 2009-10-13 | Hemoteq Ag | Dispositivo medico para el tratamiento de estenosis de pasajes corporales y para la prevencion de reestenosis inminente. |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
US7956100B2 (en) * | 2007-09-28 | 2011-06-07 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from block copolymers |
JP5502751B2 (ja) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | 低残留溶媒濃度を有する微粒子を調製するためのプロセス |
US20090306769A1 (en) * | 2008-06-06 | 2009-12-10 | Boston Scientific Scimed, Inc. | Medical balloon made with hybrid polymer-ceramic material and method of making and using the same |
US9198968B2 (en) * | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8114429B2 (en) | 2008-09-15 | 2012-02-14 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8128951B2 (en) | 2008-09-15 | 2012-03-06 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8257722B2 (en) | 2008-09-15 | 2012-09-04 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8822610B2 (en) | 2008-12-22 | 2014-09-02 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
US8815971B2 (en) | 2008-12-22 | 2014-08-26 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
WO2010123574A1 (en) | 2009-04-23 | 2010-10-28 | Atrp Solutions Inc | Star macromolecules for personal and home care |
US9783628B2 (en) | 2009-04-23 | 2017-10-10 | ATRP Solutions, Inc. | Dual-mechanism thickening agents for hydraulic fracturing fluids |
US8173750B2 (en) | 2009-04-23 | 2012-05-08 | ATRP Solutions, Inc. | Star macromolecules for personal and home care |
JP2012532670A (ja) | 2009-07-10 | 2012-12-20 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 薬剤搬送バルーンのためのナノ結晶の使用 |
WO2011008393A2 (en) | 2009-07-17 | 2011-01-20 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
US20110097368A1 (en) * | 2009-10-23 | 2011-04-28 | Cao Group, Inc. | Treatment Varnish Compositions for Teeth Surfaces |
US8889211B2 (en) | 2010-09-02 | 2014-11-18 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
US9587064B2 (en) | 2010-12-08 | 2017-03-07 | ATRP Solutions, Inc. | Salt-tolerant star macromolecules |
US8669360B2 (en) | 2011-08-05 | 2014-03-11 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
CA2882832C (en) | 2012-08-30 | 2021-08-24 | ATRP Solutions, Inc. | Dual mechanism thickening agents for hydraulic fracturing fluids |
CN105263978B (zh) | 2013-02-04 | 2018-04-17 | Atrp解决方案公司 | 耐盐星形大分子 |
US20150025608A1 (en) | 2013-07-22 | 2015-01-22 | Cardiac Pacemakers, Inc. | Lubricious, biocompatible hydrophilic thermoset coating using interpenetrating hydrogel networks |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
US10336848B2 (en) | 2014-07-03 | 2019-07-02 | Pilot Polymer Technologies, Inc. | Surfactant-compatible star macromolecules |
CN107847737B (zh) | 2015-07-25 | 2021-03-02 | 心脏起搏器股份公司 | 具有生物稳定的pvdf基材料的医用电引线 |
CN110325224B (zh) | 2016-12-27 | 2023-01-31 | 波士顿科学国际有限公司 | 用于电纺的可降解支架 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US45706A (en) * | 1865-01-03 | Improvement in apparatus for aerating dough | ||
US4847324A (en) * | 1988-04-25 | 1989-07-11 | Hydromer, Inc. | Hydrophilic polyvinylbutyral alloys |
US4946899A (en) | 1988-12-16 | 1990-08-07 | The University Of Akron | Thermoplastic elastomers of isobutylene and process of preparation |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
US5258020A (en) | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
DE69433381T3 (de) | 1993-07-29 | 2009-04-16 | The Government of the United States of America, as represented by the Secretary National Institute of Health, Office of Technology Transfer | Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators |
US5502092A (en) | 1994-02-18 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Biocompatible porous matrix of bioabsorbable material |
AU4952096A (en) * | 1995-04-19 | 1996-11-07 | Schneider (Usa) Inc. | Drug release coated stent |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5741331A (en) | 1996-07-29 | 1998-04-21 | Corvita Corporation | Biostable elastomeric polymers having quaternary carbons |
US5879697A (en) | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
WO1998056312A1 (en) | 1997-06-13 | 1998-12-17 | Scimed Life Systems, Inc. | Stents having multiple layers of biodegradable polymeric composition |
US6110483A (en) * | 1997-06-23 | 2000-08-29 | Sts Biopolymers, Inc. | Adherent, flexible hydrogel and medicated coatings |
JP2001514936A (ja) * | 1997-08-13 | 2001-09-18 | ボストン サイエンティフィック コーポレイション | 水不溶性薬剤の装填および放出 |
US6306166B1 (en) | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
US6997885B2 (en) * | 1998-04-08 | 2006-02-14 | Senorx, Inc. | Dilation devices and methods for removing tissue specimens |
US6280411B1 (en) | 1998-05-18 | 2001-08-28 | Scimed Life Systems, Inc. | Localized delivery of drug agents |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
US20020045706A1 (en) | 1998-09-22 | 2002-04-18 | Houston Michael R. | Biomedical molding materials from semi-solid precursors |
US6443980B1 (en) * | 1999-03-22 | 2002-09-03 | Scimed Life Systems, Inc. | End sleeve coating for stent delivery |
US6306419B1 (en) * | 2000-02-23 | 2001-10-23 | Aegis Biosciences, Llc | Medical uses of styrene sulfonate polymers |
KR20020076265A (ko) * | 2000-11-30 | 2002-10-09 | 가부시키가이샤 이가키 이료 세케이 | 혈관용 스텐트 및 혈관용 스텐트용 소재 |
US6545097B2 (en) * | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
US7175873B1 (en) * | 2001-06-27 | 2007-02-13 | Advanced Cardiovascular Systems, Inc. | Rate limiting barriers for implantable devices and methods for fabrication thereof |
SE523216C2 (sv) | 2001-07-27 | 2004-04-06 | Zoucas Kirurgkonsult Ab | Heparinstent |
US20030236513A1 (en) | 2002-06-19 | 2003-12-25 | Scimed Life Systems, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
US7396539B1 (en) * | 2002-06-21 | 2008-07-08 | Advanced Cardiovascular Systems, Inc. | Stent coatings with engineered drug release rate |
DE60331552D1 (de) * | 2002-08-13 | 2010-04-15 | Medtronic Inc | Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren |
CA2494187A1 (en) * | 2002-08-13 | 2004-02-19 | Medtronic, Inc. | Active agent delivery system including a polyurethane, medical device, and method |
-
2003
- 2003-03-06 US US10/382,552 patent/US8313759B2/en not_active Expired - Fee Related
-
2004
- 2004-03-05 EP EP04718104A patent/EP1599229A2/en not_active Withdrawn
- 2004-03-05 WO PCT/US2004/006853 patent/WO2004080397A2/en active Application Filing
- 2004-03-05 JP JP2006509193A patent/JP4662556B2/ja not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006520673A5 (ja) | ||
JP4473390B2 (ja) | ステント及びステントグラフト | |
US20080075833A1 (en) | Rate-reducing membrane for release of an agent | |
US20100272773A1 (en) | Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device | |
JP2005512959A5 (ja) | ||
EP1747030B1 (en) | Medical devices and methods of making the same | |
EP1135178B1 (en) | Polymeric coatings with controlled delivery active agents | |
EP2442841B1 (en) | Implantable medical devices and coatings therefor comprising block copolymers of poly (ethylene glycol) and a poly (lactide-glycolide) | |
US20030072868A1 (en) | Methods of forming a coating for a prosthesis | |
US20050238686A1 (en) | Coating for implantable devices and a method of forming the same | |
US7045142B2 (en) | Sustained release of superoxide dismutase mimics from implantable of insertable medical devices | |
JP2004533409A5 (ja) | ||
JP2001512354A (ja) | 被覆された移植可能な医療器具 | |
EP0747069A3 (en) | Implantable medical device | |
AU2005247363A1 (en) | Method of manufacturing a covered stent | |
WO2004017892A3 (en) | Drug eluting coatings for medical implants | |
US20220008231A1 (en) | Stent having a tacky silicone coating to prevent stent migration | |
EP1978957A2 (en) | Pharmaceutical compounds that contain nanoparticles useful for treating restenotic lesions | |
EP2205292B1 (en) | Therapeutic agent-eluting medical devices having textured polymeric surfaces | |
US7407668B2 (en) | Medical articles having enzymatic surfaces for localized therapy | |
WO2005097224A1 (ja) | ポリマー被覆型ステント | |
Lim et al. | The effect of alpha lipoic acid in a porcine in-stent restenosis model | |
Slepian | Polymeric endoluminal paving: A family of evolving methods for extending endoluminal therapeutics beyond stenting | |
CN109966564A (zh) | 载药球囊及其制备方法 | |
JP4456322B2 (ja) | ステント |